Promus Capital’s CVS Health CVS Stock Holding History

Promus Capital’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$16.4K	Hold	217	–	–	0.01%	232
2025 Q2	$15K	Hold	217	–	–	0.01%	242
2025 Q1	$14.7K	Hold	217	–	–	0.01%	230
2024 Q4	$9.74K	Buy	+217	New	+$12.2K	0.01%	242

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Promus Capital's CVS Position: Q3 2025 in Review

Promus Capital held its CVS Health (CVS) position steady in Q3 2025 at 217 shares worth $16.4K. The position accounts for 0.01% of the portfolio, ranked #232.

Promus Capital first reported a position in CVS in Q4 2024 and has held it in 4 quarters since. 1,834 funds tracked by Wall St. Rank hold CVS as of Q3 2025.

Promus Capital held 217 shares of CVS Health worth $16.4K as of Q3 2025.
Promus Capital left its CVS Health share count unchanged in Q3 2025.
CVS Health made up 0.01% of Promus Capital's portfolio in Q3 2025, its #232 holding.
Promus Capital first reported a position in CVS Health in Q4 2024 and has held it in 4 quarters since.
1,834 funds tracked by Wall St. Rank held CVS Health as of Q3 2025.

Based on Promus Capital's 13F filing for Q3 2025, filed 13 Nov 2025.